We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

KV Targets Citigroup Over $72M In Illiquid ARS

Law360 (February 25, 2009, 12:00 AM EST) -- KV Pharmaceutical Co. has targeted Citigroup Global Markets Inc. with a suit that accuses the bank of inducing the drug manufacturer to invest in auction rate securities and leaving it in...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.